Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 178.51% | -16.19% | -42.05% | -80.09% | -66.89% |
| Total Depreciation and Amortization | 45.53% | 75.61% | 184.14% | 221.97% | 161.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.88% | 182.24% | 483.93% | 622.39% | 419.59% |
| Change in Net Operating Assets | 67.27% | 16.33% | -97.70% | -75.90% | -26.71% |
| Cash from Operations | 166.13% | 113.82% | 104.62% | 41.33% | 29.66% |
| Capital Expenditure | -35.35% | -47.47% | -64.38% | -57.02% | -29.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 98.37% | 94.04% | 94.60% | -844.36% | -824.60% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.78% | -106.35% | 20.39% | 1,518.76% | 3,531.04% |
| Cash from Investing | -99.22% | -158.11% | 418.29% | 402.74% | 387.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 979.80% | 790.85% | 57.18% | -42.80% | -71.80% |
| Repurchase of Common Stock | 39.48% | 60.83% | -- | -- | -124.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.99% | -467.47% | -401.40% | -394.73% | -394.19% |
| Cash from Financing | -56.18% | 88.05% | -1,805.35% | -1,214.00% | -209.97% |
| Foreign Exchange rate Adjustments | 742.50% | -88.30% | 147.99% | 4,653.19% | -70.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.39% | 0.10% | 136.01% | -33.21% | 1,226.71% |